Showing session: reset
Anti-Ras Drug Discovery: Mission Impossible?
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
New targets on the KRAS pathway
Frank McCormick
UCSF Helen Diller Family Comp. Cancer Ctr., San Francisco, CA, United States
- Permission not
granted for presentation
Targeting ERK effector signaling for the treatment of KRAS mutant pancreaticcancer
Channing J. Der
UNC Lineberger Comp. Cancer Ctr., Chapel Hill, NC, United States
- Permission not
granted for presentation
Targeting oncogenic Ras: One size doesn’t fit all
Dafna Bar-Sagi
New York Univ. Langone Medical Ctr., New York, NY, United States
- Permission not
granted for presentation
Exploiting fragility in oncogenic Ras signaling networks
Michael A. White
UT Southwestern Medical Ctr., Dallas, TX, United States